Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.96 USD | -0.01% |
|
+4.90% | -13.64% |
Jul. 11 | Morgan Stanley Adjusts Price Target on Gilead Sciences to $74 From $78 | MT |
Jul. 09 | RBC Cuts Price Target on Gilead Sciences to $71 From $74, Keeps Sector Perform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.64% | 87.16B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Wells Fargo Cuts Price Target on Gilead Sciences to $78 From $84, Keeps Equalweight Rating